Economic Evaluations of CAR-T Cell Therapies for Hematologic and Solid Malignancies: A Systematic Review

This study aims to systematically review evidence on the cost-effectiveness of chimeric antigen receptor (CAR)-T therapies for patients with cancer.

Source: Value in Health - April 16, 2024 Category: International Medicine & Public Health Authors: Kednapa Thavorn, Emily Thompson, Srishti Kumar, Aliisa Heiskanen, Anubhav Agarwal, Harold Atkins, Risa Shorr, Terry Hawrysh, Kelvin Kar-Wing Chan, Justin Presseau, Daniel A. Ollendorf, Ian D. Graham, Jeremy M. Grimshaw, Manoj Mathew Lalu, Surapon Nochaiwo Tags: Systematic Literature Review Source Type: research